Orchidpharma Inc is categorized under Wholesale Pharmaceutical Products in Princeton, NJ and active since 2010.
Orchidpharma Inc was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Satish Srinivasan at the company’s headquarters by writing to 105 College Road East # 200, Princeton, New Jersey NJ 08540 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Orchidpharma Inc |
| Contact Person: | Satish Srinivasan |
| Address: | 105 College Road East # 200, Princeton, New Jersey 08540 |
| Website Address: | karalexpharma.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Orchidpharma Inc was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Satish Srinivasan for inquiries that concern Orchidpharma Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Orchidpharma Inc can be found at the coordinates 40.356334,-74.602181 as well as the street address 105 College Road East # 200 in Princeton, New Jersey 08540.
For its online presence, you may visit Orchidpharma Inc’s website at karalexpharma.com and engage with its social media outlets through on Twitter and on Facebook.